# Efficacy and Safety of Oral Probiotics on Ocular Symptoms and Gut Microbiome of Children with Vernal Keratoconjunctivitis

> **NCT06793514** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Mohsen Pourazizi** · enrollment: 32 (estimated)

## Conditions studied

- Probiotic
- Ocular Surface Disease
- Ocular Diseases
- Ocular Dryness
- Gut Microbiome Dysbiosis
- Gut -microbiota

## Interventions

- **DRUG:** Probiotic
- **DRUG:** Placebo Drug

## Key facts

- **NCT ID:** NCT06793514
- **Lead sponsor:** Mohsen Pourazizi
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-02-01
- **Primary completion:** 2025-05-01
- **Final completion:** 2025-06-01
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2025-01-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06793514

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06793514, "Efficacy and Safety of Oral Probiotics on Ocular Symptoms and Gut Microbiome of Children with Vernal Keratoconjunctivitis". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT06793514. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*